Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUMMIT: SLITone Ultra HDM Mix in Allergic Rhinitis
NCT01728298Phase 2Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2012
- Primary completion
- Aug 2013
- Modality
- Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of SLITone Dermatophagoides mix in allergic rhinitis (AR), sponsored by ALK-Abelló. Started Nov 2012; status: completed.
02
Drugs
SLITone Dermatophagoides mix
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01728298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728298.